This report aims to provide a comprehensive presentation of the global market for Kidney Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer. This report contains market size and forecasts of Kidney Cancer in global, including the following market information:
Global Kidney Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Kidney Cancer market was valued at US$ 435.1 million in 2022 and is projected to reach US$ 656.4 million by 2029, at a CAGR of 6.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of Kidney Cancer include Pfizer, Exelixis, Bristol-Myers Squibb, Novartis, etc. Global top four manufacturers hold a share over 35%. North America has the largest number of Kidney cancer, holds a share of about 50%. In terms of product, targeted therapy is the largest segment, with a share over 45%. And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.
We surveyed the Kidney Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Kidney Cancer Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Kidney Cancer Market Segment Percentages, by Type, 2022 (%)
Surgery
Immunotherapy
Targeted Therapy
Other
Global Kidney Cancer Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Kidney Cancer Market Segment Percentages, by Application, 2022 (%)
Renal Cell Carcinoma
Renal Pelvis Cancer
Other
Global Kidney Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Kidney Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Kidney Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Kidney Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Novartis
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Aveo Pharmaceuticals
Bayer
Exelixis
Eisai
Outline of Major Chapters:
Chapter 1: Introduces the definition of Kidney Cancer, market overview.
Chapter 2: Global Kidney Cancer market size in revenue.
Chapter 3: Detailed analysis of Kidney Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Kidney Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Kidney Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kidney Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney Cancer Overall Market Size
2.1 Global Kidney Cancer Market Size: 2022 VS 2029
2.2 Global Kidney Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Kidney Cancer Players in Global Market
3.2 Top Global Kidney Cancer Companies Ranked by Revenue
3.3 Global Kidney Cancer Revenue by Companies
3.4 Top 3 and Top 5 Kidney Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Kidney Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Kidney Cancer Players in Global Market
3.6.1 List of Global Tier 1 Kidney Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Kidney Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Kidney Cancer Market Size Markets, 2022 & 2029
4.1.2 Surgery
4.1.3 Immunotherapy
4.1.4 Targeted Therapy
4.1.5 Other
4.2 By Type - Global Kidney Cancer Revenue & Forecasts
4.2.1 By Type - Global Kidney Cancer Revenue, 2018-2023
4.2.2 By Type - Global Kidney Cancer Revenue, 2024-2029
4.2.3 By Type - Global Kidney Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Kidney Cancer Market Size, 2022 & 2029
5.1.2 Renal Cell Carcinoma
5.1.3 Renal Pelvis Cancer
5.1.4 Other
5.2 By Application - Global Kidney Cancer Revenue & Forecasts
5.2.1 By Application - Global Kidney Cancer Revenue, 2018-2023
5.2.2 By Application - Global Kidney Cancer Revenue, 2024-2029
5.2.3 By Application - Global Kidney Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Kidney Cancer Market Size, 2022 & 2029
6.2 By Region - Global Kidney Cancer Revenue & Forecasts
6.2.1 By Region - Global Kidney Cancer Revenue, 2018-2023
6.2.2 By Region - Global Kidney Cancer Revenue, 2024-2029
6.2.3 By Region - Global Kidney Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Kidney Cancer Revenue, 2018-2029
6.3.2 US Kidney Cancer Market Size, 2018-2029
6.3.3 Canada Kidney Cancer Market Size, 2018-2029
6.3.4 Mexico Kidney Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Kidney Cancer Revenue, 2018-2029
6.4.2 Germany Kidney Cancer Market Size, 2018-2029
6.4.3 France Kidney Cancer Market Size, 2018-2029
6.4.4 U.K. Kidney Cancer Market Size, 2018-2029
6.4.5 Italy Kidney Cancer Market Size, 2018-2029
6.4.6 Russia Kidney Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Kidney Cancer Market Size, 2018-2029
6.4.8 Benelux Kidney Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Kidney Cancer Revenue, 2018-2029
6.5.2 China Kidney Cancer Market Size, 2018-2029
6.5.3 Japan Kidney Cancer Market Size, 2018-2029
6.5.4 South Korea Kidney Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Kidney Cancer Market Size, 2018-2029
6.5.6 India Kidney Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Kidney Cancer Revenue, 2018-2029
6.6.2 Brazil Kidney Cancer Market Size, 2018-2029
6.6.3 Argentina Kidney Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Kidney Cancer Revenue, 2018-2029
6.7.2 Turkey Kidney Cancer Market Size, 2018-2029
6.7.3 Israel Kidney Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Kidney Cancer Market Size, 2018-2029
6.7.5 UAE Kidney Cancer Market Size, 2018-2029
7 Kidney Cancer Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Kidney Cancer Major Product Offerings
7.1.4 Merck Kidney Cancer Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Kidney Cancer Major Product Offerings
7.2.4 Novartis Kidney Cancer Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Kidney Cancer Major Product Offerings
7.3.4 Bristol-Myers Squibb Kidney Cancer Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Kidney Cancer Major Product Offerings
7.4.4 Pfizer Kidney Cancer Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Kidney Cancer Major Product Offerings
7.5.4 Roche Kidney Cancer Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Kidney Cancer Major Product Offerings
7.6.4 Amgen Kidney Cancer Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Aveo Pharmaceuticals
7.7.1 Aveo Pharmaceuticals Company Summary
7.7.2 Aveo Pharmaceuticals Business Overview
7.7.3 Aveo Pharmaceuticals Kidney Cancer Major Product Offerings
7.7.4 Aveo Pharmaceuticals Kidney Cancer Revenue in Global Market (2018-2023)
7.7.5 Aveo Pharmaceuticals Key News & Latest Developments
7.8 Bayer
7.8.1 Bayer Company Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Kidney Cancer Major Product Offerings
7.8.4 Bayer Kidney Cancer Revenue in Global Market (2018-2023)
7.8.5 Bayer Key News & Latest Developments
7.9 Exelixis
7.9.1 Exelixis Company Summary
7.9.2 Exelixis Business Overview
7.9.3 Exelixis Kidney Cancer Major Product Offerings
7.9.4 Exelixis Kidney Cancer Revenue in Global Market (2018-2023)
7.9.5 Exelixis Key News & Latest Developments
7.10 Eisai
7.10.1 Eisai Company Summary
7.10.2 Eisai Business Overview
7.10.3 Eisai Kidney Cancer Major Product Offerings
7.10.4 Eisai Kidney Cancer Revenue in Global Market (2018-2023)
7.10.5 Eisai Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Kidney Cancer Market Opportunities & Trends in Global Market
Table 2. Kidney Cancer Market Drivers in Global Market
Table 3. Kidney Cancer Market Restraints in Global Market
Table 4. Key Players of Kidney Cancer in Global Market
Table 5. Top Kidney Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Kidney Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Kidney Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Kidney Cancer Product Type
Table 9. List of Global Tier 1 Kidney Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Kidney Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Kidney Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Kidney Cancer Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Kidney Cancer Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Kidney Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Kidney Cancer Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Kidney Cancer Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Kidney Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Kidney Cancer Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Kidney Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Kidney Cancer Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Kidney Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Kidney Cancer Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Kidney Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Kidney Cancer Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Kidney Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Kidney Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Kidney Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Kidney Cancer Revenue, (US$, Mn), 2024-2029
Table 30. Merck Company Summary
Table 31. Merck Kidney Cancer Product Offerings
Table 32. Merck Kidney Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Kidney Cancer Product Offerings
Table 36. Novartis Kidney Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Kidney Cancer Product Offerings
Table 40. Bristol-Myers Squibb Kidney Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Kidney Cancer Product Offerings
Table 44. Pfizer Kidney Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Kidney Cancer Product Offerings
Table 48. Roche Kidney Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Kidney Cancer Product Offerings
Table 52. Amgen Kidney Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Aveo Pharmaceuticals Company Summary
Table 55. Aveo Pharmaceuticals Kidney Cancer Product Offerings
Table 56. Aveo Pharmaceuticals Kidney Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Aveo Pharmaceuticals Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Kidney Cancer Product Offerings
Table 60. Bayer Kidney Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Bayer Key News & Latest Developments
Table 62. Exelixis Company Summary
Table 63. Exelixis Kidney Cancer Product Offerings
Table 64. Exelixis Kidney Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Exelixis Key News & Latest Developments
Table 66. Eisai Company Summary
Table 67. Eisai Kidney Cancer Product Offerings
Table 68. Eisai Kidney Cancer Revenue (US$, Mn) & (2018-2023)
Table 69. Eisai Key News & Latest Developments
List of Figures
Figure 1. Kidney Cancer Segment by Type in 2022
Figure 2. Kidney Cancer Segment by Application in 2022
Figure 3. Global Kidney Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Kidney Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Kidney Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Kidney Cancer Revenue in 2022
Figure 8. By Type - Global Kidney Cancer Revenue Market Share, 2018-2029
Figure 9. By Application - Global Kidney Cancer Revenue Market Share, 2018-2029
Figure 10. By Type - Global Kidney Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Kidney Cancer Revenue Market Share, 2018-2029
Figure 12. By Application - Global Kidney Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Kidney Cancer Revenue Market Share, 2018-2029
Figure 14. By Region - Global Kidney Cancer Revenue Market Share, 2018-2029
Figure 15. By Country - North America Kidney Cancer Revenue Market Share, 2018-2029
Figure 16. US Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Kidney Cancer Revenue Market Share, 2018-2029
Figure 20. Germany Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 21. France Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Kidney Cancer Revenue Market Share, 2018-2029
Figure 28. China Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. India Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Kidney Cancer Revenue Market Share, 2018-2029
Figure 34. Brazil Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Kidney Cancer Revenue Market Share, 2018-2029
Figure 37. Turkey Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Kidney Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. Merck Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Aveo Pharmaceuticals Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bayer Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Exelixis Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eisai Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
